StonvexLoading…
StonvexStonvexStonvexCore line items from CBLL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $89.06M | $65.44M | $45.23M |
Operating Income | $-58.40M | $-39.71M | $-30.04M |
Net Income | $-53.41M | $-40.45M | $-29.46M |
EPS (Diluted) | $-1.46 | $-3.39 | $-5.56 |
Total Assets | $195.80M | $225.41M | $58.92M |
Total Liabilities | $40.47M | $34.25M | $23.76M |
Cash & Equivalents | $40.48M | $194.37M | $34.49M |
Free Cash Flow OCF − CapEx | $-41.58M | $-36.38M | $-30.14M |
Shares Outstanding | 37.49M | 35.85M | 5.43M |